Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001

Vox Sanguinis

Volumn 84, Issue 4, 2003, Pages 274-286

  Soldan, K ^a,b   Barbara, J A J ^b   Ramsay, M E ^a   Hall, A J ^c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Blood donors; HBV; HCV; HIV; Transfusion transmitted infection

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ACCURACY; ADULT; ARTICLE; ASSAY; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; CALCULATION; DISEASE TRANSMISSION; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; QUANTITATIVE ANALYSIS; SAFETY; SENSITIVITY ANALYSIS; SEROCONVERSION; STATISTICAL ANALYSIS; TIME; TORQUE TENO VIRUS; UNITED KINGDOM;

BLOOD DONORS; BLOOD TRANSFUSION; ENGLAND; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; PREVALENCE; RISK; SEROLOGIC TESTS;

EID: 0038118506     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2003.00296.x     Document Type: Article

References (25)

1. Soldan K, Barbara JAJ, Heptonstall J: Incidence of seroconversion to positivity for hepatitis C antibody in repeat blood donors in England, 1993-95. BMJ 1998; 316:1413-1417
2. Hoofnagle JH, Seeff LB, Buskell-Bales Z et al.: Serological responses in HB; in Vyas GN, Cohen SN, Schmid R (eds): Viral Hepatitis: a Contemporary Assessment of Aetiology, Epidemiology, Pathogenesis and Prevention. Philadelphia, Franklin Institute Press, 1978:219-242
3. Mimms LT, Mosley JW, Hollinger FB, Aach RD, Stevens CE, Cunningham M, Vallari DV, Barbosa LH, Nemo GJ: Effect of concurrent acute infection with hepatitis C on acute hepatitis B virus infection. BMJ 1993; 307:1095-1097
4. Hoofnagle JH, Schaffer DF: Serological markers of hepatitis B virus infection [review]. Semin Liver Dis 1986; 6:1-10
5. Lackritz EM, Satten GA, Aberle-Grasse J et al.: Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995; 333:1721-1725
6. Cumming PD, Wallace EL, Schorr JB, Dodd RY: Exposure of patients to HIV through the transfusion of blood components that test antibody negative. N Engl J Med 1989; 321:941-946
7. Dax EM, Healey DS, Crofts N: Low risk of HIV-1 infection from blood donation: a test-based estimate [Letter]. Med J Aust 1992; 157:69
8. Schriber GB, Busch MP, Kleinman SH, Korelitz JJ: The risk of transfusion-transmitted viral infections. N Engl J Med 1996; 334:1685-1690
9. Busch MP, Lee LL, Satten GA et al.: Time course of detection of viral and serological markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissues donors. Transfusion 1995; 35:91-97
10. Barrera JM, Francis B, Ercilla G, Nelles M, Achord D, Darner J, Lee SR: Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang 1995; 68:15-18 [Also personal communication with the authors.]
11. Gluck D, Kubanek B, Maurer C, Petersen N: Seroconversion of HIV, HCV, and HBV in blood donors in 1996 - risk of virus transmission by blood products in Germany. Infus Ther Transfus Med 1998; 25:82-84
12. Muller-Breitkreutz K: Results of viral marker screening of unpaid blood donations in 1997 and probability of window period donations. Vox Sang 2000; 78:149-157
13. Medical Devices Agency: Ten anti-HCV screening assays. London, Medical Devices Agency, 1995, MDA/95/03. (http://www.medical-devices.gov.uk)
14. rd Generation Plus EIA. London, Medical Devices Agency, 1998, MDA/98/03. (http://www.medical-devices.gov.uk)
15. Linden JV, Kaplan HS: Transfusion errors: causes and effects. Transfus Med Rev 1994; 8:169-183
16. Linden JV: Error contributes to the risk of transmissible disease. Transfusion 1994; 34:1016
17. Soldan K, Barbara JAJ, Dow BC: Transfusion-transmitted HBV infection in the UK: a small and moving target. Vox Sang 2002; 83:305-308
18. Schreiber GB, Busch MP, Kleinman SH: The risk of transfusion transmitted viral infections. N Engl J Med 1996; 334:1685-1690
19. Courouce AM, Pillonel J: Estimation du risque transmission des virus des hepatitis B et C, et des retrovirus par transfusion de derives sanguins labiles. Bull Epidemiol Hebdormadaire 1996; 11:54-55
20. Love EM, Williamson LM, Cohen H, Jones H, Todd A, Soldan K, Revill J, Norfolk DR, Barbara J, Atterbury C, Asher D: SHOT Annual Report 1998-1999. Manchester, SHOT Office, Manchester Blood Centre, 2000
21. Soldan K, Sinka K: Evaluation of the de-selection of men, who have had sex with men, from blood donation in England. Vox Sang 2003; 84:000-000
22. Martlew VJ, Carey P, William Tong CY, Parry JV, Belda FJ, Barlow KL, Chu P, Syed Q: Post-transfusion HIV infection despite donor screening. A Report of three cases. J Hosp Infect 2000; 44:93-97
23. Crawford RJ, Mitchell R, Burnett AK, Follett EAC: Who may give blood? BMJ 1987; 294:572
24. Asher D, Atterbury C, Chapman C, Cohen H, Jones H, Love EM, Norfolk DR, Revill J, Soldan K, Todd A, Williamson LM: SHOT Annual Report 2000-2001. Manchester, SHOT Office, Manchester Blood Centre, 2002
25. Regan FAM, Hewitt PE, Barbara JAJ, Contreras M: Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. BMJ 2000; 320:403-406